These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 14714688)

  • 1. The perils of gene patents.
    Salzberg SL
    Clin Pharmacol Ther; 2012 Jun; 91(6):969-71. PubMed ID: 22609909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The locked code.
    Watts G
    BMJ; 2007 May; 334(7602):1032-3. PubMed ID: 17510149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmful uses of patentable neurotechnology: a new regulatory approach : Proposing a framework safeguarding human rights and social responsibility for patented applications of neuroscience.
    Nadler RR; Spranger TM; Rotenberg A; Barretto TA; Hansmann J; Hemmer A; Kiss ZH; Madden JD; Strong MJ; Illes J
    EMBO Rep; 2024 May; 25(5):2156-2161. PubMed ID: 38580879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sculpting genomes with a hammer and chisel.
    Conklin BR
    Nat Methods; 2013 Sep; 10(9):839-40. PubMed ID: 23985729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Open Source Seed Licence: A novel approach to safeguarding access to plant germplasm.
    Kotschi J; Horneburg B
    PLoS Biol; 2018 Oct; 16(10):e3000023. PubMed ID: 30352056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open Genetic Code: on open source in the life sciences.
    Deibel E
    Life Sci Soc Policy; 2014; 10():2. PubMed ID: 26573980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and patent policy: rethinking intellectual property rights.
    Andrews LB
    Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady the course: property rights in genetic material.
    Epstein RA
    Adv Genet; 2003; 50():153-94; discussion 507-10. PubMed ID: 14714690
    [No Abstract]   [Full Text] [Related]  

  • 10. Patenting genetic products and processes: a TRIPS perspective.
    McManis CR
    Adv Genet; 2003; 50():79-96; discussion 507-10. PubMed ID: 14714687
    [No Abstract]   [Full Text] [Related]  

  • 11. Myriad diagnostic concerns.
    Nat Biotechnol; 2013 Jul; 31(7):571. PubMed ID: 23839123
    [No Abstract]   [Full Text] [Related]  

  • 12. Varying the course in patenting genetic material: a counter-proposal to Richard Epstein's steady course.
    Dreyfuss RC
    Adv Genet; 2003; 50():195-208; discussion 507-10. PubMed ID: 14714691
    [No Abstract]   [Full Text] [Related]  

  • 13. Saving the patent law from itself: informal remarks concerning the systemic problems afflicting developed intellectual property regimes.
    Reichman JH
    Adv Genet; 2003; 50():289-303; discussion 507-10. PubMed ID: 14714697
    [No Abstract]   [Full Text] [Related]  

  • 14. Enclosing the genome: what squabbles over genetic patents could teach us.
    Boyle J
    Adv Genet; 2003; 50():97-122; discussion 507-10. PubMed ID: 14714688
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.